Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 10

    1.

    Long-term safety and effects of tesamorelin, a growth hormone-releasing factor analogue, in HIV patients with abdominal fat accumulation.

    Falutz J, Allas S, Mamputu JC, Potvin D, Kotler D, Somero M, Berger D, Brown S, Richmond G, Fessel J, Turner R, Grinspoon S.

    AIDS. 2008 Sep 12;22(14):1719-28.PMID: 18690162 [PubMed - indexed for MEDLINE]Related articles

    2.

    Contribution of metabolic and anthropometric abnormalities to cardiovascular disease risk factors.

    Grunfeld C, Kotler DP, Arnett DK, Falutz JM, Haffner SM, Hruz P, Masur H, Meigs JB, Mulligan K, Reiss P, Samaras K; Working Group 1.

    Circulation. 2008 Jul 8;118(2):e20-8. Epub 2008 Jun 19. No abstract available. PMID: 18566314 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    HIV-associated lipodystrophy syndrome: A review of clinical aspects.

    Baril JG, Junod P, Leblanc R, Dion H, Therrien R, Laplante F, Falutz J, Côté P, Hébert MN, Lalonde R, Lapointe N, Lévesque D, Pinault L, Rouleau D, Tremblay C, Trottier B, Trottier S, Tsoukas C, Weiss K.

    Can J Infect Dis Med Microbiol. 2005 Jul;16(4):233-43.PMID: 18159551 [PubMed - in process]Related articlesFree article

    4.

    Metabolic effects of a growth hormone-releasing factor in patients with HIV.

    Falutz J, Allas S, Blot K, Potvin D, Kotler D, Somero M, Berger D, Brown S, Richmond G, Fessel J, Turner R, Grinspoon S.

    N Engl J Med. 2007 Dec 6;357(23):2359-70.PMID: 18057338 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Therapy insight: Body-shape changes and metabolic complications associated with HIV and highly active antiretroviral therapy.

    Falutz J.

    Nat Clin Pract Endocrinol Metab. 2007 Sep;3(9):651-61. Review.PMID: 17710086 [PubMed - indexed for MEDLINE]Related articles

    6.

    Functional T cell subsets contribute differentially to HIV peptide-specific responses within infected individuals: correlation of these functional T cell subsets with markers of disease progression.

    Peretz Y, Ndongala ML, Boulet S, Boulassel MR, Rouleau D, Côté P, Longpré D, Routy JP, Falutz J, Tremblay C, Tsoukas CM, Sékaly RP, Bernard NF.

    Clin Immunol. 2007 Jul;124(1):57-68. Epub 2007 May 22.PMID: 17521962 [PubMed - indexed for MEDLINE]Related articles

    7.

    A placebo-controlled, dose-ranging study of a growth hormone releasing factor in HIV-infected patients with abdominal fat accumulation.

    Falutz J, Allas S, Kotler D, Thompson M, Koutkia P, Albu J, Trottier B, Routy JP, Cote P, Abribat T, Grinspoon S.

    AIDS. 2005 Aug 12;19(12):1279-87.PMID: 16052083 [PubMed - indexed for MEDLINE]Related articles

    8.

    Update on HIV/HAART associated morphologic and metabolic abnormalities.

    Falutz J.

    Forum Nutr. 2003;56:158-62. Review. No abstract available. PMID: 15806844 [PubMed - indexed for MEDLINE]Related articles

    9.

    Bone mineral and soft-tissue changes in AIDS-associated lipoatrophy.

    Rosenthall L, Falutz J.

    J Bone Miner Metab. 2005;23(1):53-7.PMID: 15616895 [PubMed - indexed for MEDLINE]Related articles

    10.

    Clinical evaluation and management of metabolic and morphologic abnormalities associated with human immunodeficiency virus.

    Wanke CA, Falutz JM, Shevitz A, Phair JP, Kotler DP.

    Clin Infect Dis. 2002 Jan 15;34(2):248-59. Epub 2001 Dec 7. Review.PMID: 11740715 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...